 |
ataluren |
|---|---|
| Trade Name | |
| Orphan Indication | Spinal muscular atrophy |
| USA Market Approval | USA |
| USA Designation Date | 2008-03-10 00:00:00 |
| Sponsor | PTC Therapeutics, Inc.;100 Corporate Court;South Plainfield, New Jersey, 07080 |
Related Access Program
Pfizer – Non Small Cell Lung Cancer With ALK or ROS1 Rearrangement
Pfizer – Non Small Cell Lung Cancer Harboring Molecular Alterations
Biogen – Infantile-onset Spinal Muscular Atrophy
Novartis Pharmaceuticals – Non-small Cell Lung Cancer (NSCLC)
Biogen – Infantile-onset Spinal Muscular Atrophy (SMA)